Abstract
Because of rapid aging and unhealthy life style in most of Asian countries, non-communicable diseases are increasing gradually and become significant disease burden and socioeconomic burden in Asia. However, the level of hypertension management is not good especially in the young adults. Clinical decision-making for hypertension in the elderly should not depend on chronological age alone. Global risk assessment for individual patients, including comorbidities, frailty, functional status, polypharmacy, cognitive impairment, and variable life expectancy and the risk of orthostatic hypotension should be done for better management of hypertension and outcome. There are many conflicting results and discrepancies on the optimal target BP in elderly hypertensive patients. Asians are different from Caucasians in genetic background, pathophysiology, clinical phenotypes, respond to medication, prognosis and etc. Although there are several hypertension guidelines in Asia, development of hypertension management guidelines for Asians is needed through pooled national cohort data, big health data analysis for precision medicine of hypertension. Hypertension is also good candidate for the digital smart healthcare in the near future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
